Remission in depression: definition and initial treatment approaches

被引:50
作者
Israel, JA [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA
关键词
depression; remission; diagnosis; selective serotonin reuptake inhibitors (SSRIs); tricyclic antidepressants (TCAs); monoamine oxidase inhibitors (MAOIs); antidepressant therapy;
D O I
10.1177/1359786806064306
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although remission is recognized as the optimal outcome of treatment for depression, remission tacks a universally accepted definition. This is partly due to the lack of objective biologic markers or tests that confirm a response to treatment and no well-defined end points of treatment. Significant symptoms may still exist even though patients may have a full response as measured by currently available standardized psychiatric rating scales. In addition, many patients may experience marked improvement in depressive symptoms but stilt have impaired psychosocial and work function. Wellness should be determined by evaluating a combination of three key domains: symptoms, functional status and pathophysiotogic changes. In choosing an initial medication for depression, physicians are often guided by a mix of evidence-based medicine and unvatidated or even inaccurate clinical tore. In general, most available agents have comparable effectiveness; however, the subtype of depression and age of the patient should be considered.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 25 条
[1]   Development of a brief screening instrument: The HANDS [J].
Baer, L ;
Jacobs, DG ;
Meszler-Reizes, J ;
Blais, M ;
Fava, M ;
Kessler, R ;
Magruder, K ;
Murphy, J ;
Kopans, B ;
Cukor, P ;
Leahy, L ;
O'Laughlen, J .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2000, 69 (01) :35-41
[2]   Neuroimaging studies of mood disorders [J].
Drevets, WC .
BIOLOGICAL PSYCHIATRY, 2000, 48 (08) :813-829
[3]   Definition and epidemiology of treatment-resistant depression [J].
Fava, M ;
Davidson, KG .
PSYCHIATRIC CLINICS OF NORTH AMERICA, 1996, 19 (02) :179-&
[4]   CONCEPTUALIZATION AND RATIONALE FOR CONSENSUS DEFINITIONS OF TERMS IN MAJOR DEPRESSIVE DISORDER - REMISSION, RECOVERY, RELAPSE, AND RECURRENCE [J].
FRANK, E ;
PRIEN, RF ;
JARRETT, RB ;
KELLER, MB ;
KUPFER, DJ ;
LAVORI, PW ;
RUSH, AJ ;
WEISSMAN, MM .
ARCHIVES OF GENERAL PSYCHIATRY, 1991, 48 (09) :851-855
[5]   Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs [J].
Hirschfeld, RMA .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (05) :326-335
[6]   Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination [J].
Hirschfeld, RMA ;
Dunner, DL ;
Keitner, G ;
Klein, DN ;
Koran, LM ;
Kornstein, SG ;
Markowitz, JC ;
Miller, I ;
Nemeroff, CB ;
Ninan, PT ;
Rush, AJ ;
Schatzberg, AF ;
Thase, ME ;
Trivedi, MH ;
Borian, FE ;
Crits-Christoph, P ;
Keller, MB .
BIOLOGICAL PSYCHIATRY, 2002, 51 (02) :123-133
[7]   A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender [J].
Joyce, PR ;
Mulder, RT ;
Luty, SE ;
McKenzie, JM ;
Rae, AM .
ACTA PSYCHIATRICA SCANDINAVICA, 2003, 108 (01) :20-23
[8]   Past, present, and future directions for defining optimal treatment outcome in depression - Remission and beyond [J].
Keller, MB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (23) :3152-3160
[9]   How do you define remission? [J].
Lecrubier, Y .
ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 :7-11
[10]   Depression with atypical features in the national comorbidity survey - Classification, description, and consequences [J].
Matza, LS ;
Revicki, DA ;
Davidson, JR ;
Stewart, JW .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (08) :817-826